Novel molecular biomarkers at the blood-brain barrier in ALS - Wikidata - thesis-toulmin - TriplyDB

Novel molecular biomarkers at the blood-brain barrier in ALS

Novel molecular biomarkers at the blood-brain barrier in ALS

http://www.wikidata.org/entity/Q27004431

about

KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels.Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.Immunoglobulins G from Sera of Amyotrophic Lateral Sclerosis Patients Induce Oxidative Stress and Upregulation of Antioxidative System in BV-2 Microglial Cell Line.

P2860

Q37714956-5A02F5D1-7F44-48FF-8477-9B0C2061A6AB Q39449749-6C53AAE5-E8D6-4933-8984-C810ACCFD327 Q46245616-C1B040E7-074A-46AF-95EC-AC67E62D38C6

P2860

Novel molecular biomarkers at the blood-brain barrier in ALS

http://www.wikidata.org/entity/Q27004431

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Novel molecular biomarkers at the blood-brain barrier in ALS

@ast

Novel molecular biomarkers at the blood-brain barrier in ALS

@en

Novel molecular biomarkers at the blood-brain barrier in ALS

@nl

type

label

Novel molecular biomarkers at the blood-brain barrier in ALS

@ast

Novel molecular biomarkers at the blood-brain barrier in ALS

@en

Novel molecular biomarkers at the blood-brain barrier in ALS

@nl

prefLabel

Novel molecular biomarkers at the blood-brain barrier in ALS

@ast

Novel molecular biomarkers at the blood-brain barrier in ALS

@en

Novel molecular biomarkers at the blood-brain barrier in ALS

@nl

P1433

Q27004431-E0835459-9044-4B2C-B259-4D91B7AA8AAE

P1476

Q27004431-67238839-6674-4F30-AC5A-C11E585CB12D

P2093

Q27004431-5C967083-11B4-47CE-B2C8-CE0D61F52E3D

Q27004431-8E035C88-6E72-4A14-B0C8-5BE89BBCAF6B

P275

Q27004431-8E31D02A-298C-4B7E-B3D1-9BF5D25A8975

P2860

Q27004431-083D2CEF-BE22-4025-8E43-D2D6ED71E6F9

Q27004431-0BBC6C9D-0A23-4D0E-8209-F58C5B89E172

Q27004431-0C167017-26DB-4172-A648-FEE29868D57F

Q27004431-0F6887D7-AC71-43AF-BBA5-8814B1FD1A90

Q27004431-12436449-09DF-427B-8073-BF625A0B4878

Q27004431-15BE9957-D4D2-41AB-AC67-C3D3C0BEA1DE

Q27004431-15D71CD2-175E-4AE8-87D5-71B88D06C91E

Q27004431-1A8D006D-5C8D-4A1F-A0A7-34BC749CDF8B

Q27004431-1BBBFA17-EE5B-4A5D-B7D1-FC261CED888E

Q27004431-218303F1-FBAE-4F9D-AF41-F7ACCD8388EC

P304

Q27004431-6125CEFC-6E14-4534-873B-E708E6EC15D1

P31

Q27004431-6A0DA876-BC37-48C9-AD31-31E688AF54B7

P356

Q27004431-A585FB42-2C9C-41A4-9172-554EC250E8C2

P407

Q27004431-DFC543D5-9F06-49A0-A74C-07769A908D1F

P478

Q27004431-EA43AB70-EDB3-473F-9319-DE91C8B3488D

P50

Q27004431-25B7F0A2-D367-4014-B4CE-FF654A8967E1

Q27004431-657A8D17-EE38-4D6F-B368-144CBA321474

P5008

Q27004431-E09CB482-4719-49F8-A9A1-FA739ABE859E

P577

Q27004431-FBA903C0-BED5-45C7-A336-F4A9D0CBEF74

P5875

Q27004431-EBC3CC2E-10D1-43AC-8968-18D41E6D6B10

P698

Q27004431-7FC9C0C2-8D51-4904-8EFD-671766837DC8

P921

Q27004431-3E17422E-81CA-4DD6-A4E7-8990BF2057EA

Q27004431-959F8DA3-36D6-4029-BFC1-8A1C5B3287C9

Q27004431-A8561576-6F25-4023-9C95-971772FB995B

Q27004431-A96775C7-FF2A-49C5-987F-2F2931EF08AC

Q27004431-ACEE9E46-1C07-45DC-A342-624C06B94EA3

Q27004431-E5A8F499-00A9-4C2C-B65E-21F0598798C8

P932

Q27004431-CB43B9E2-FB40-4ACA-91E7-50499BED38DE

P356

P1433

BioMed Research International

P1476

Novel molecular biomarkers at the blood-brain barrier in ALS

@en

P2093

Danijela Bataveljic

http://www.w3.org/2001/XMLSchema#string

Pavle Andjus

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

The blood-brain barrier in health and chronic neurodegenerative disorders

Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis

Onset and progression in inherited ALS determined by motor neurons and microglia

Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats

Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS.

P304

907545

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/907545

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Lidija Radenovic

Milena Milosevic

P5008

P577

2014-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263289201

http://www.w3.org/2001/XMLSchema#string

P698

24949481

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

amyotrophic lateral sclerosis

blood–brain barrier

P932

4037612

http://www.w3.org/2001/XMLSchema#string